Atopic dermatitis (AD), also known as eczema, is a chronic inflammatory skin disease marked by itchy and inflamed skin. It is one of the most common skin diseases, especially among children, but it can persist into adulthood or start at an older age.

Over the decades, research has evolved from viewing AD merely as an allergic condition to understanding its complex pathophysiology involving epidermal barrier dysfunction, immune dysregulation, and environmental and psychological factors.

This shift has been pivotal in shaping current therapeutic strategies which aim to restore barrier function, reduce immune dysregulation, and manage environmental and lifestyle factors.

iNGENū’s team of researchers and clinicians is dedicated to advancing atopic dermatitis research. Through innovative trial designs and a patient-centered approach, we work to accelerate the development of new treatments that could offer improved options and outcomes for those affected by Atopic Dermatitis.